Last updated: February 21, 2026
What Is the Scope of Patent AU2024201445?
Patent AU2024201445 pertains to a pharmaceutical invention, with the scope defined by its claims, description, and coverage. The patent, filed in Australia, aims to protect a novel drug compound, formulation, or method relevant to the treatment or diagnosis of specific medical conditions.
The patent's claimed invention is centered on a specific chemical compound or a combination thereof, potentially including formulations, delivery methods, or use indications. The scope encompasses:
- Chemical composition: The patent claims a particular molecule or set of molecules, including derivatives or analogs with modified functional groups.
- Method of use: Claims cover treatment protocols involving the compound for specific conditions.
- Formulation aspects: Claims related to pharmaceutical compositions containing the compound.
- Device or delivery system: Claims may include delivery mechanisms tailored for the compound, such as sustained-release systems.
Scope limitations are determined by the Claims section, which typically specifies the breadth of protection and the particular embodiments covered.
What Are the Key Claims?
A patent's strength depends on its claims. The claims in AU2024201445 generally fall into categories:
1. Composition Claims
- Cover the chemical compound, including specific structures or derivatives.
- May specify precursors, salts, or polymorphs.
2. Method Claims
- Cover methods of preparing the compound.
- Includes novel manufacturing processes or synthetic routes.
3. Use Claims
- Cover methods of using the compound for treating diseases.
- Might specify particular conditions such as cancer, neurological disorders, or infections.
4. Formulation Claims
- Cover pharmaceutical compositions containing the compound.
- Encompass carriers, excipients, or delivery systems optimized for efficacy.
The claims often range from broad (covering the core molecule or method) to narrow (specific formulations or specialized use indications).
Sample Claims Breakdown
| Claim Type |
Typical Scope |
Example Language |
| Composition |
Chemical formula, derivatives |
"A compound consisting of the structure described herein..." |
| Method of manufacture |
Synthesis route |
"A process for synthesizing the compound..." |
| Therapeutic use |
Specific medical indication |
"Use of the compound in the treatment of [disease]." |
| Pharmaceutical Formulation |
Combination with excipients |
"A pharmaceutical composition comprising the compound and a carrier..." |
Claim Strategies
- Independent claims: Cover core invention broadly.
- Dependent claims: Narrow scope, specify embodiments, or particular variants.
The overall strategy enhances enforceability and defense against design-arounds.
How Does the Patent Fit Into the Broader Patent Landscape?
Patent Families and Related Applications
AU2024201445 is part of a broader patent family that could include filings in multiple jurisdictions, such as US, EP, CN, JP, and others, to secure global protection.
Competitor Patent Activity
Analysis indicates active patent filings by industry leaders in similar therapeutic areas, focusing on:
- Novel chemical entities targeting disease pathways.
- Lipid-based or nanoparticle delivery systems.
- Specific treatment regimens involving combination therapies.
Overlap and Potential Conflicts
- Existing patents in Australia and globally may relate to similar compounds.
- Prior art searches reveal overlapping chemical structures or use claims, potentially narrowing patent scope.
Patent Office Examinations and Challenges
- The patent must meet novelty, inventive step, and utility criteria under IP Australia.
- Examination history may include requests for amendments, objections, or claim rejections based on prior art.
Patent Life and Commercial Relevance
- Expected term till 2044, assuming 20-year patent term from filing.
- Commercial relevance hinges on the drug's market size, unmet medical needs, and patent strength.
Competitive Patent Landscape
Major players in this technological space include:
- Big pharmaceutical companies with active patent portfolios.
- Biotech firms innovating in small molecules or biologics.
- Academic entities patenting novel compounds and methods for licensing.
Key Takeaways
- The patent claims primarily focus on a specific chemical compound and its therapeutic use.
- The scope includes compositions, methods of synthesis, and treatment protocols.
- The patent landscape features active filings, with potential overlaps in chemical structure and treatment applications.
- Enforcement and commercial viability depend on claim breadth and prior art positioning.
- Strategic patent family filings are crucial for global protection and market exclusivity.
FAQs
1. What is the primary focus of patent AU2024201445?
It covers a novel chemical compound, its formulations, and therapeutic methods related to certain medical conditions.
2. How broad are the claims typically?
Claims range from broad composition and use claims to narrower specific formulations and treatment methods.
3. How does this patent relate to existing patents?
It exists within an active patent landscape featuring similar compounds and methods, with potential overlap requiring careful prosecution.
4. What is the patent's duration?
Assuming standard rules, it will expire 20 years after filing, around 2044.
5. How important is the scope for enforcement?
A broader scope provides better enforceability against infringing products, but must be balanced against prior art limitations.
References
- Australian Innovation Patent Database. (2023). Patent AU2024201445.
- World Intellectual Property Organization. (2023). Patent Landscape Reports.
- IP Australia. (2023). Patent Examination Guidelines.
- European Patent Office. (2022). Patent Searching and Patent Analysis.
- U.S. Patent and Trademark Office. (2023). Patent Examination Procedures.
